The biotech has named Jamie Coleman its chief commercial officer, per a Monday announcement, putting her in charge of the ...

It’s available only by prescription for people with a body mass ... alongside a balanced diet and regular exercise, you may lose weight. Zepbound helps you lose weight by reducing your appetite.

Both of these GLP-1 drugs were originally designed for diabetes, but their benefits keep expanding — KSTP health expert Dr.

A high dose of Novo Nordisk’s obesity drug Wegovy led patients to lose substantial weight in a clinical trial, but still less ...

Zepbound is a medicine you can obtain only by prescription, and it's typically used to address obesity and other ...

The study included people taking different types drugs in this category—semaglutide (Wegovy and Ozempic), and tirzepatide (Mounjaro and Zepbound). While tirzepatide targets two hormones—GLP-1 ...

As demand for weight-loss injections sold under brand names such as Ozempic and Wegovy continues to soar, a study has ...

People who stayed on a 7.2 milligram weekly dose of semaglutide lost around 20% of their body weight over 72 weeks.

Eli Lilly has since joined the FDA as a defendant to try to make sure the shortage stays resolved — it wants people taking and paying for its Monjauro and Zepbound, not cheaper copies.

Demand for weight-loss medications sold under brand names such as Ozempic and Wegovy continues to surge, with a recent study ...